- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics, Lipid Disorders, and Treatment Options
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 96, Issue 1, Pages 36-47
Publisher
Springer Nature
Online
2014-04-10
DOI
10.1038/clpt.2014.82
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic Myopathies Discovered During Investigations of Statin Myopathy
- (2014) Steven K. Baker et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- The 2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol
- (2014) Henry N. Ginsberg CIRCULATION RESEARCH
- Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy
- (2013) Jacqueline S. Danik et al. AMERICAN HEART JOURNAL
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update
- (2013) G.B. John Mancini et al. CANADIAN JOURNAL OF CARDIOLOGY
- 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2013) Todd J. Anderson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Western Database of Lipid Variants (WDLV): A Catalogue of Genetic Variants in Monogenic Dyslipidemias
- (2013) Jennifer Fu et al. CANADIAN JOURNAL OF CARDIOLOGY
- Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia
- (2013) Evan A. Stein et al. CIRCULATION
- Clinical and Pharmacogenetic Predictors of Circulating Atorvastatin and Rosuvastatin Concentrations in Routine Clinical Care
- (2013) Marianne K. DeGorter et al. Circulation-Cardiovascular Genetics
- Genetics and Personalized Medicine—a Role in Statin Therapy?
- (2013) Jaideep Patel et al. Current Atherosclerosis Reports
- The spectrum of statin myopathy
- (2013) Payam Mohassel et al. CURRENT OPINION IN RHEUMATOLOGY
- Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
- (2013) Rajiv Chowdhury et al. EUROPEAN HEART JOURNAL
- Current Phase II proprotein convertase subtilisin/kexin 9 inhibitor therapies for dyslipidemia
- (2013) Paul Lee et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education
- (2013) Melissa Y. Wei et al. Journal of Clinical Lipidology
- Novel gene-by-environment interactions:APOBandNPC1L1variants affect the relationship between dietary and total plasma cholesterol
- (2013) Daniel S. Kim et al. JOURNAL OF LIPID RESEARCH
- RareAPOA5promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy
- (2013) Ariel Brautbar et al. JOURNAL OF LIPID RESEARCH
- Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk
- (2013) Gregory S. Thomas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A statin-dependent QTL for GATM expression is associated with statin-induced myopathy
- (2013) Lara M. Mangravite et al. NATURE
- Statin myotoxicity: A review of genetic susceptibility factors
- (2013) M. Needham et al. NEUROMUSCULAR DISORDERS
- The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study
- (2013) Catherine E. de Keyser et al. Pharmacogenetics and Genomics
- Pharmacogenomics of lipid-lowering therapies
- (2013) Miao Hu et al. PHARMACOGENOMICS
- Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction
- (2012) Daniel I. Chasman et al. Circulation-Cardiovascular Genetics
- The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy
- (2012) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
- (2012) Jemma C. Hopewell et al. EUROPEAN HEART JOURNAL
- Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
- (2012) Harshal A. Deshmukh et al. JOURNAL OF LIPID RESEARCH
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study
- (2012) A C Frazier-Wood et al. PHARMACOGENOMICS JOURNAL
- Genome-Wide Study of Gene Variants Associated with Differential Cardiovascular Event Reduction by Pravastatin Therapy
- (2012) Dov Shiffman et al. PLoS One
- Variants Identified in a GWAS Meta-Analysis for Blood Lipids Are Associated with the Lipid Response to Fenofibrate
- (2012) Stella Aslibekyan et al. PLoS One
- Meta-Analyses of KIF6 Trp719Arg in Coronary Heart Disease and Statin Therapeutic Effect
- (2012) Ping Peng et al. PLoS One
- Mechanisms of statin-induced myalgia assessed by physiogenomic associations
- (2011) Gualberto Ruaño et al. ATHEROSCLEROSIS
- Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly
- (2011) Hironobu Akao et al. ATHEROSCLEROSIS
- Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses
- (2011) Stella Trompet et al. BMC Medical Genetics
- Lack of Association of KIF6 Genotype With Vascular Disease and Statin Response
- (2011) Kiran Musunuru Circulation-Cardiovascular Genetics
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
- (2011) L R Brunham et al. PHARMACOGENOMICS JOURNAL
- Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy
- (2011) M L Becker et al. PHARMACOGENOMICS JOURNAL
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
- (2010) L A Donnelly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin
- (2010) B Tomlinson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1
- (2010) Stefan Oswald et al. Pharmacogenetics and Genomics
- Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations
- (2010) Mathew J. Barber et al. PLoS One
- Identification of Genetic Variants Associated With Response to Statin Therapy
- (2009) Jessica L. Mega et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort
- (2009) John F. Thompson et al. Circulation-Cardiovascular Genetics
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER
- (2008) Eliana Polisecki et al. ATHEROSCLEROSIS
- Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population
- (2008) Eliana Polisecki et al. ATHEROSCLEROSIS
- Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment
- (2008) Ronald M. Krauss et al. CIRCULATION
- Association of the Trp719Arg Polymorphism in Kinesin-Like Protein 6 With Myocardial Infarction and Coronary Heart Disease in 2 Prospective Trials
- (2008) Olga A. Iakoubova et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy
- (2008) Philippe Couvert et al. PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More